Shares of InterCure Ltd. (NASDAQ:INCR - Get Free Report) shot up 3.5% during mid-day trading on Tuesday . The company traded as high as $1.33 and last traded at $1.33. 4,407 shares traded hands during trading, a decline of 87% from the average session volume of 34,804 shares. The stock had previously closed at $1.28.
InterCure Price Performance
The stock has a fifty day moving average of $1.49 and a 200-day moving average of $1.56. The company has a current ratio of 1.78, a quick ratio of 1.15 and a debt-to-equity ratio of 0.15.
Hedge Funds Weigh In On InterCure
A number of hedge funds have recently added to or reduced their stakes in INCR. Moore Capital Management LP purchased a new position in InterCure during the 4th quarter worth $156,000. Virtu Financial LLC bought a new position in shares of InterCure during the 3rd quarter worth $43,000. Finally, Jane Street Group LLC purchased a new position in shares of InterCure during the third quarter valued at $49,000. 8.34% of the stock is currently owned by institutional investors.
InterCure Company Profile
(
Get Free Report)
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil.
Featured Articles
Before you consider InterCure, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and InterCure wasn't on the list.
While InterCure currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Like this article? Share it with a colleague.
Link copied to clipboard.
